Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.8K
Ligand Binding Sites02:40

Ligand Binding Sites

9.1K
9.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Protein-Protein Interfaces02:04

Protein-Protein Interfaces

4.6K
4.6K
Conserved Binding Sites01:49

Conserved Binding Sites

2.0K
2.0K
Conserved Binding Sites01:49

Conserved Binding Sites

5.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strategic Template Filtering Accelerates Fragment-Based Peptide Docking.

Journal of chemical information and modeling·2026
Same author

Rescuing the Function of Missense-Mutated Tumor Suppressor <i>VHL</i> using Stabilizing Small Molecules.

bioRxiv : the preprint server for biology·2026
Same author

Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis.

Molecular cancer research : MCR·2026
Same author

PPIscreenML is a method for structure-based screening of protein-protein interactions using AlphaFold.

eLife·2026
Same author

Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosis.

bioRxiv : the preprint server for biology·2025
Same author

Reliable protein-protein docking with AlphaFold, Rosetta, and replica exchange.

eLife·2025

Related Experiment Video

Updated: Apr 7, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K

DARC 2.0: Improved Docking and Virtual Screening at Protein Interaction Sites.

Ragul Gowthaman1, Sergey Lyskov2, John Karanicolas3

  • 1Center for Computational Biology, University of Kansas, 2030 Becker Dr., Lawrence, KS, 66045, United States of America.

Plos One
|July 17, 2015
PubMed
Summary

We enhanced DARC (Docking Approach using Ray Casting), a computational method for drug discovery, to improve small molecule targeting of protein-protein interactions. The updated DARC 2.0 significantly boosts accuracy and speed in predicting drug binding poses.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

31
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.6K

Related Experiment Videos

Last Updated: Apr 7, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

31
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.6K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Structural biology

Background:

  • Protein-protein interactions are key therapeutic targets but challenging for small molecule drugs.
  • Traditional virtual screening methods are less effective for shallow protein interaction sites.

Purpose of the Study:

  • To present five key enhancements to the DARC (Docking Approach using Ray Casting) method.
  • To improve the accuracy and speed of docking small molecules to protein interaction sites.

Main Methods:

  • DARC 2.0 incorporates multiple vantage points for surface complementarity.
  • Introduced rapid weighting schemes, on-the-fly ligand conformer sampling, and electrostatic complementarity scoring.
  • Optimized GPU implementation for faster calculations.

Main Results:

  • The enhanced DARC 2.0 achieved 2 Å RMSD accuracy for 12 out of 25 protein-ligand complexes.
  • This represents a statistically significant improvement over the original DARC method.
  • Demonstrated dramatically improved speed and performance.

Conclusions:

  • The five enhancements collectively form DARC 2.0, significantly advancing small molecule drug discovery for protein-protein interactions.
  • DARC 2.0 offers a more powerful and efficient tool for identifying potential therapeutics targeting challenging protein interfaces.